Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Johnson and Johnson
Medtronic
AstraZeneca
Dow

Last Updated: December 7, 2021

DrugPatentWatch Database Preview

Navinta Llc Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for NAVINTA LLC, and what generic and branded alternatives to NAVINTA LLC drugs are available?

NAVINTA LLC has fifteen approved drugs.



Summary for Navinta Llc
US Patents:0
Tradenames:15
Ingredients:15
NDAs:15
Drug Master File Entries: 25

Drugs and US Patents for Navinta Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Navinta Llc REMIFENTANIL HYDROCHLORIDE remifentanil hydrochloride INJECTABLE;INJECTION 210594-002 Oct 13, 2020 AP RX No No ⤷  Try it Free ⤷  Try it Free
Navinta Llc INDOMETHACIN SODIUM indomethacin sodium INJECTABLE;INJECTION 206561-001 Jul 19, 2017 AP RX No Yes ⤷  Try it Free ⤷  Try it Free
Navinta Llc NICARDIPINE HYDROCHLORIDE nicardipine hydrochloride INJECTABLE;INJECTION 090125-001 Nov 17, 2009 DISCN No No ⤷  Try it Free ⤷  Try it Free
Navinta Llc FOMEPIZOLE fomepizole INJECTABLE;INJECTION 078537-001 Mar 6, 2008 AP RX No No ⤷  Try it Free ⤷  Try it Free
Navinta Llc PENICILLAMINE penicillamine CAPSULE;ORAL 214363-001 Oct 8, 2021 AB RX No No ⤷  Try it Free ⤷  Try it Free
Navinta Llc BENZTROPINE MESYLATE benztropine mesylate INJECTABLE;INJECTION 091525-001 Feb 5, 2013 AP RX No No ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Medtronic
McKesson
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.